CareTrust REIT (CTRE) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.39
- Estimate
- $0.39
- Surprise
- +0.3%
- Revenue (period 2026-06-30)
- $4.6M
- Score at report (before → after)
- 4.9 → 5.0/10
Revenue source: xbrl.
How the report landed
CareTrust REIT (CTRE) reported adjusted EPS of $0.39, in line with the $0.39 estimate. TrendMatrix's engine moved from Buy (Wait) (4.9/10) to Sell at 5.0/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CTRE Sell at 6.1/10.
0 of the last 4 quarters beat the estimate; this quarter's +0.3% surprise compares with a -5.2% four-quarter average. Next scheduled report: 2026-11-05.
What supports the rating
- Outperforming peers
- Wide economic moat
What argues against it
- Thin upside margin: 7.1%
- Sector modifier (Real Estate): -1.2
- Earnings in 7 days (event risk)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $35.45
- Price target
- $37.97
- Stop
- $34.10
- Upside to target
- +7.1%
- Reward-to-risk
- 1.4:1
At 22.2× trailing and 18.9× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-10-29 — shown for context, not personalized investment advice.
CTRE at TrendMatrix's latest read
REIT quarters hinge on occupancy, rate exposure, and FFO rather than headline EPS, which mechanically distorts under depreciation.
- Industry
- REIT - Healthcare Facilities
- Market cap
- $8.38B
- P/E (fwd)
- 18.9
- P/E (ttm)
- 22.2
- 52-week range
- $33.72–$43.62
- Off 52-week high
- 18.7%
- RSI (14)
- 47
- Volume vs avg
- 1.48×
- Score today
- 6.1/10